Testimonials

Since Tri-Solfen^® was commercially launched, over 150 million lambs have been treated and over 80% of Australian wool growers are now using Tri-Solfen for their sheep. Here’s what some of them have to say…

‘We have used pain relief for two years now and seen real production gains. We are concerned for the welfare of our animals and will continue to use pain relief to ensure they get the best care.’

Clinton Wise– Wililoo Merino Stud, Woodanilling, W.A.

'It easy to see the difference pain relief makes. Before, lambs would walk away hunched up, even taking a couple of hours to walk back to the paddock. Now they run straight back to Mum and start suckling,” says Rod. “My wool is now sold under the Better Choices brand. I see this as a definite advantage. I think it will be an advantage in the long run, to both me and the industry as a whole.'

Rod Miller– Glenpaen Merino Stud, Horsham, Vic

'After being treated with pain relief my lambs were more content and less stressed. As farmers we are sincere in looking after the welfare of our animals and using pain relief demonstrates this.'

Richard Coole– Frankland, W.A.

'We have been using pain relief for the past three years. We’re impressed by reduced bleeding in the mulesing wound immediately after application. Lambs run straight back to find the ewe, which has dramatically reduced our mortality rates. Flock management, post lamb marking is easier due to the effect of pain relief and the scab healing faster.'

Ryan & Malcom O’Dea– Peepingee Merino Stud, Narrogin, W.A.

'Using pain relief eases the stress and allows lambs to mother up and move back to the paddock easier with faster weight gains.'

Kent Lummis– Waverley Downs, Gilgandra, NSW

Country	Species	Patent
Australia	Sheep	Granted
Australia	Horses, Dogs, Lab animals	Granted
Australia	Cattle	Granted
Australia	Humans	Granted
New Zealand	Sheep, Cattle	Granted
New Zealand	Horses, Dogs, Lab animals	Granted
EU	Humans	Granted
EU	Pig, Sheep, Cattle	Granted
USA	Dogs, Horses, Lab animals	Granted
USA	Humans	Granted
USA	Pig, Sheep, Cattle	Granted
Canada	Horses, Dogs, Lab animals	Granted
Canada	Cattle, Pig	Granted
Canada	Humans	Granted

Advisory Board

Ian Page

Non-Executive Director

Ian is Chief Executive Officer of Dechra Pharmaceuticals, which has a 33% shareholder in Medical Ethics. He joined National Veterinary Services, Dechra’s former services business in 1989 and joined the Board of Dechra in 1997. In October 2010, Ian was appointed as Non-Executive Chairman of Sanford DeLand Asset Management.

Dr Chris Roberts

Human Wound and Regulatory Advisor

Chris has over 20 years’ line management experience of heading clinical research teams. He was previously global head of Smith & Nephew clinical support and market development, where he managed global clinical Phase II and III programmes in the management of venous and pressure ulcers.

Lieutenant Colonel Professor Steven Jeffery

Medical Specialist Advisor

Steve has over 15 years’ experience in military plastic surgery. In 2011 he was awarded the Military Civilian Partnership Award for ‘Regular of the Year’, as well as receiving the Wounds UK ‘Key Contribution’ award and the Smith and Nephew ‘Customer Pioneer of the Year’ award. He has also been awarded Fellowship of the Royal College of Surgeons of England ad eundum. He is an expert adviser to NICE Medical Technologies Evaluation Programme. Steve co-founded the Woundcare 4 Heroes charity, which is already making a big difference to the wound care of both serving and veteran personnel.

Dr Matthew Bayfield

Medical Specialist Scientific Director

Dr Matthew Bayfield, Head of Cardiothoracic Surgery, Strathfield Private Hospital and VMO Cardiothoracic Surgeon, Royal Prince Alfred Hospital.

Professor Peter Windsor

Veterinarian Research Advisor

Peter is a registered specialist veterinary surgeon in New South Wales and an emeritus Professor at Sydney University. He holds a BVSc (Hons), PhD, DVSc and diploma from the European College of Small Ruminant Health Management.

Dr Julian Braidwood

Global Regulatory Affairs Advisor

Julian has held leadership roles and managed international clinical projects with Grampian. He was previously Regulatory Affairs Manager at Novartis Animal Health. He is the Founder and Managing Director of Triveritas, where he is responsible for a team of 40 animal health specialists across the EU and the US.

Tri–Solfen^®

Tri-Solfen^® is a local anaesthetic and antiseptic gel spray that adheres well to wounds and acts as a barrier to environmental stimuli, promotes haemostasis and improves wound healing. Tri-Solfen^® contains two proven topical local anaesthetics; fast-acting Lignocaine for immediate pain relief and long-acting bupivacaine for prolonged post-operative pain relief. Adrenaline is included for its ability to reduce the shock and stress of blood loss, whilst prolonging the anaesthetic action. Tri-Solfen^® also contains Cetrimide; an antiseptic widely used to cleanse skin and wounds and provides protection from bacterial contamination.

Key concepts driving farm animal care progress for producers

December 18, 2013

Seven ideas that matter:- A look at several key questions and concepts driving farm animal care progress for livestock producers and their industry

It may be the dog days of summer but in the world of farm animal care it’s also a time when new ideas and fresh progress are heating up. Here’s a rundown of several key questions and concepts to watch for in the months ahead.

1. Who pays?

It’s an unprecedented time of new standards and opportunities for innovation in farm animal care, but a key question on the minds of many is who will carry the short-term investment burden required for significant practice and infrastructure change. With numerous potential shifts on the horizon, “The cost of transition must be spread across the value chain” is a statement producers will get used to hearing more often from their associations.

2. Who should pay?

Hot on the heels of this debate is the related question of consumer demand and whether or not consumers will ultimately pay more for perceived welfare-enhanced products.

3. Social license.

This term has been among the leading buzzwords for why livestock producers and their industries need to get and stay ahead of the game in managing the welfare issue. It follows that food producers who build trust with the public by showing they have good practices in place will enjoy greater freedom to operate.

4. Progress payoff.

Canada has been among the most progressive countries in taking the social license argument to heart in recent years, by driving progress with new Codes of Practice and a variety of shifts toward assessment approaches. We’ll see better now how much this translates into improved standing with consumers and the general public.

5. Market access.

Will livestock welfare become a market access issue? The signs are pointing in that direction, but time will tell how quickly and significantly this step takes hold. Many agree animal welfare is moving from the fringes toward the core of discussions in many arenas, including trade.

6. Benchmarking.

Dr. Temple Grandin said it best: “You can’t manage what you can’t measure.” This is just one of many strong reasons why benchmarking studies are increasingly important to provide a basis for not only making farm animal care progress but proving it.

7. Owning the issue.

Livestock welfare, simply put, is what livestock producers do every day. Sometimes it’s easy to lose sight of that amid the flurry of debate and pressure that flows from everything from animal rights activists to consumers who want to know more about where their food comes from. Producers represent the front line of farm animal care and many believe that producers need to ‘own’ this role more strongly and openly than ever as the best way to manage this issue for a successful future.

Email alerts